XML 43 R2.htm IDEA: XBRL DOCUMENT
v3.25.1

Pay vs Performance Disclosure | 12 Months Ended
--- | ---
Dec. 31, 2024 USD ($) | Dec. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | Dec. 31, 2020 USD ($)
Pay vs Performance Disclosure |  |  |  |  |
Pay vs Performance Disclosure, Table | Pay Versus Performance Comparison As discussed in the Compensation Discussion and Analysis above, our Compensation Committee has implemented an executive compensation program designed to link a substantial portion of our named executive officers’ realized compensation to the achievement of BeiGene’s financial, operational, and strategic objectives, and to align our executive pay with changes in the value of our shareholders’ investments. Pursuant to SEC rules, the Pay Versus Performance table set forth directly below is required to include “Compensation Actually Paid” to the CEO and the average “Compensation Actually Paid” to the non-CEO NEOs. “Compensation Actually Paid” is an SEC defined term that represents a calculation of compensation that differs significantly from both the compensation paid to the executive during the year, as well as the Summary Compensation Table calculation of compensation, as described in footnote 2 of the below table. For example, the “Compensation Actually Paid” calculation for a given year includes the change in fair value of multiple years of equity grants that are outstanding and unvested during the year, or which vested during the year, whereas the Summary Compensation Table calculation includes only the fair value of equity awards granted during the year. Furthermore, the equity included in the “Compensation Actually Paid to CEO” column includes equity granted to our CEO which was granted in 2015, prior to the Company’s initial public offering. This difference result in a “Compensation Actually Paid” calculation that is significantly impacted by changes in stock price and may be higher or lower than the corresponding Summary Compensation Table calculation. The following table sets forth such compensation information for our named executive officers calculated in accordance with SEC regulations, for fiscal years 2024, 2023, 2022, 2021 and 2020.
​ | ​ | ​ | Summary Compensation Table Total for CEO ($)(1) | ​ | ​ | Compensation Actually Paid to CEO ($)(2) | ​ | ​ | Average Summary Compensation Table Total for Non-CEO NEOs ($)(3) | ​ | ​ | Average Compensation Actually Paid to Non-CEO NEOs ($)(2)(3) | ​ | ​ | Value of Initial Fixed US$100 Investment Based On: | ​ | ​ | Net Income (Loss) ($) | ​ | ​ | Global Revenue ($)(5) | ​
Year | ​ | ​ | Total Shareholder Return ($) | ​ | ​ | Peer Group Total Shareholder Return ($)(4) | ​
2024 | ​ | ​ | 20,836,439 | ​ | ​ | 14,972,388 | ​ | ​ | 7,938,281 | ​ | ​ | 6,673,955 | ​ | ​ | 111 | ​ | ​ | 118 | ​ | ​ | (644,786,000) | ​ | ​ | 3,810,241,000 | ​
2023 | ​ | ​ | 18,925,730 | ​ | ​ | 11,431,433 | ​ | ​ | 7,108,129 | ​ | ​ | 6,652,989 | ​ | ​ | 109 | ​ | ​ | 119 | ​ | ​ | (881,708,000) | ​ | ​ | 2,458,779,000 | ​
2022 | ​ | ​ | 18,047,667 | ​ | ​ | 11,216,389 | ​ | ​ | 6,355,270 | ​ | ​ | 3,367,166 | ​ | ​ | 133 | ​ | ​ | 114 | ​ | ​ | (2,003,815,000) | ​ | ​ | 1,415,921,000 | ​
2021 | ​ | ​ | 16,748,546 | ​ | ​ | 22,876,853 | ​ | ​ | 5,143,513 | ​ | ​ | 5,761,306 | ​ | ​ | 163 | ​ | ​ | 126 | ​ | ​ | (1,457,816,000) | ​ | ​ | 1,176,283,000 | ​
2020 | ​ | ​ | 14,409,330 | ​ | ​ | 40,749,054 | ​ | ​ | 5,178,425 | ​ | ​ | 15,276,116 | ​ | ​ | 156 | ​ | ​ | 126 | ​ | ​ | (1,624,974,000) | ​ | ​ | 308,874,000 | ​
​ (1) The dollar amounts reported are the amounts of total compensation reported for our Chief Executive Officer, John V. Oyler, in the Summary Compensation Table for fiscal years 2024, 2023, 2022, 2021 and 2020. John V. Oyler served as Chief Executive Officer for each of the years presented. ​ (2) The dollar amounts reported represent the amount of “Compensation Actually Paid”, as computed in accordance with SEC rules. The dollar amounts do not only reflect the actual amounts of compensation paid to our Chief Executive Officer or other named executive officers during the applicable year, but also include (i) the year-end value of equity awards granted during ​ (3) For 2024, reflects compensation information for our named executive officers, other than our Chief Executive Officer, as described in the Compensation Discussion and Analysis portion of this proxy statement. For 2023, reflects compensation information for Xiaobin Wu, Julia Wang, Lai Wang and Chan Lee. For 2022, reflects compensation information for Xiaobin Wu, Julia Wang, Lai Wang, and Jane Huang. For 2021, reflects compensation information for Xiaobin Wu, Lai Wang, Julia Wang, Jane Huang and Howard Liang. For 2020, reflects compensation information for Xiaobin Wu, Jane Huang and Howard Liang. ​ (4) Reflects cumulative total shareholder return of the Nasdaq Biotechnology Index, as of December 31, 2024, weighted according to the constituent companies’ market capitalization at the beginning of each period for which a return is indicated. The Nasdaq Biotechnology Index is the peer group used by the Company for purposes of Item 201(e) of Regulation S-K under the Exchange Act in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. ​ (5) The Company has identified Global Revenue as the company-selected financial measure for the pay versus performance disclosure, as it represents the most important financial performance measure used to link “Compensation Actually Paid” to the executive officers in 2024 to the Company’s performance. To calculate the amounts in the “Compensation Actually Paid to CEO” column in the table above, the following amounts were deducted from and added to (as applicable) our CEO’s “Total” compensation as reported in the Summary Compensation Table:
​ | ​ | ​ | 2024($) | ​ | ​ | 2023($) | ​ | ​ | 2022($) | ​ | ​ | 2021($) | ​ | ​ | 2020($) | ​
Summary Compensation Table Values | ​ | ​ | 20,836,439 | ​ | ​ | 18,925,730 | ​ | ​ | 18,047,667 | ​ | ​ | 16,748,546 | ​ | ​ | 14,409,330 | ​
Adjustments | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Deduction for grant date fair value amounts reported under “Share Awards” column in the Summary Compensation Table | ​ | ​ | (11,999,768) | ​ | ​ | (5,499,851) | ​ | ​ | (3,999,886) | ​ | ​ | (3,749,738) | ​ | ​ | — | ​
Deduction for grant date fair value amounts reported under “Option Awards” column in the Summary Compensation Table | ​ | ​ | (5,999,924) | ​ | ​ | (10,999,987) | ​ | ​ | (11,999,969) | ​ | ​ | (11,249,988) | ​ | ​ | (12,999,981) | ​
Year-over-Year change in the fair value of the Share Awards and Option Awards | ​ | ​ | 12,135,641 | ​ | ​ | 9,005,541 | ​ | ​ | 9,168,577 | ​ | ​ | 21,128,033 | ​ | ​ | 39,339,705 | ​
As of year-end for share awards granted during the year | ​ | ​ | 13,937,478 | ​ | ​ | 4,934,109 | ​ | ​ | 5,650,918 | ​ | ​ | 3,047,963 | ​ | ​ | — | ​
Year-over-year increase (decrease) of unvested share awards granted in prior years | ​ | ​ | (2,741,728) | ​ | ​ | (3,016,530) | ​ | ​ | (5,169,361) | ​ | ​ | (6,167,656) | ​ | ​ | (437,376) | ​
Increase (decrease) from prior fiscal year-end for share awards that vested during the year | ​ | ​ | 2,571,754 | ​ | ​ | 1,757,090 | ​ | ​ | 2,790,149 | ​ | ​ | 8,513,109 | ​ | ​ | 4,262,798 | ​
Decrease in fair value of share awards forfeited during the year | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​
As of year-end for option awards granted during the year | ​ | ​ | 7,170,732 | ​ | ​ | 8,881,173 | ​ | ​ | 19,018,564 | ​ | ​ | 8,085,256 | ​ | ​ | 21,214,314 | ​
Year-over-year increase (decrease) of unvested option awards granted in prior years | ​ | ​ | (9,374,770) | ​ | ​ | (15,862,437) | ​ | ​ | (22,568,170) | ​ | ​ | (22,321,474) | ​ | ​ | (18,976,117) | ​
Increase (decrease) from prior fiscal year-end for option awards that vested during the year | ​ | ​ | 572,175 | ​ | ​ | 12,312,136 | ​ | ​ | 9,446,478 | ​ | ​ | 29,970,835 | ​ | ​ | 33,276,085 | ​
Decrease in fair value of option awards forfeited during the year | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​
“Compensation Actually Paid” as defined by SEC rules | ​ | ​ | 14,972,388 | ​ | ​ | 11,431,433 | ​ | ​ | 11,216,389 | ​ | ​ | 22,876,853 | ​ | ​ | 40,749,054 | ​
To calculate the amounts in the “Average Compensation Actually Paid to Non-CEO NEOs” column in the table above, the following amounts were deducted from and added to (as applicable) the average of the “Total” compensation of our non-CEO named executive officers for each applicable year as reported in the Summary Compensation Table:
​ | ​ | ​ | 2024($) | ​ | ​ | 2023($) | ​ | ​ | 2022($) | ​ | ​ | 2021($) | ​ | ​ | 2020($) | ​
Average Summary Compensation Table Values | ​ | ​ | 7,938,281 | ​ | ​ | 7,108,129 | ​ | ​ | 6,355,270 | ​ | ​ | 5,143,513 | ​ | ​ | 5,178,425 | ​
Adjustments | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Deduction for average grant date fair value of amounts reported to Non-CEO NEOs under “Share Awards” column in the Summary Compensation Table | ​ | ​ | (3,879,868) | ​ | ​ | (1,961,799) | ​ | ​ | (1,530,694) | ​ | ​ | (1,301,952) | ​ | ​ | (1,066,581) | ​
Deduction for average grant date fair value of amounts reported to Non-CEO NEOs under “Option Awards” column in the Summary Compensation Table | ​ | ​ | (1,939,970) | ​ | ​ | (3,923,789) | ​ | ​ | (3,878,829) | ​ | ​ | (2,962,605) | ​ | ​ | (3,199,969) | ​
Year-over-Year change in the average fair value of the Share Awards and Option Awards | ​ | ​ | 4,555,512 | ​ | ​ | 5,430,448 | ​ | ​ | 2,421,419 | ​ | ​ | 4,882,350 | ​ | ​ | 14,364,241 | ​
As of year-end for share awards granted during the year | ​ | ​ | 3,631,546 | ​ | ​ | 1,759,998 | ​ | ​ | 2,027,077 | ​ | ​ | 773,830 | ​ | ​ | 1,579,969 | ​
Year-over-year increase (decrease) of unvested share awards granted in prior years | ​ | ​ | (629,516) | ​ | ​ | (1,396,018) | ​ | ​ | (3,171,371) | ​ | ​ | (1,711,290) | ​ | ​ | 1,084,830 | ​
Increase (decrease) from prior fiscal year-end for share awards that vested during the year | ​ | ​ | 1,219,522 | ​ | ​ | 2,656,725 | ​ | ​ | 1,518,326 | ​ | ​ | 3,166,184 | ​ | ​ | 1,653,429 | ​
Decrease in fair value of share awards forfeited during the year | ​ | ​ | (1,039,985) | ​ | ​ | — | ​ | ​ | (307,302) | ​ | ​ | (369,601) | ​ | ​ | — | ​
As of year-end for option awards granted during the year | ​ | ​ | 1,849,707 | ​ | ​ | 3,167,990 | ​ | ​ | 5,943,252 | ​ | ​ | 2,052,737 | ​ | ​ | 5,221,946 | ​
Year-over-year increase (decrease) of unvested option awards granted in prior years | ​ | ​ | (2,366,351) | ​ | ​ | (3,948,214) | ​ | ​ | (4,561,808) | ​ | ​ | (4,842,349) | ​ | ​ | (2,274,007) | ​
Increase (decrease) from prior fiscal year-end for option awards that vested during the year | ​ | ​ | 2,551,974 | ​ | ​ | 3,189,968 | ​ | ​ | 1,981,811 | ​ | ​ | 7,018,416 | ​ | ​ | 7,098,075 | ​
Decrease in fair value of option awards forfeited during the year | ​ | ​ | (661,385) | ​ | ​ | — | ​ | ​ | (1,008,565) | ​ | ​ | (1,205,576) | ​ | ​ | — | ​
Average “Compensation Actually Paid” as defined by SEC rules | ​ | ​ | 6,673,955 | ​ | ​ | 6,652,989 | ​ | ​ | 3,367,166 | ​ | ​ | 5,761,306 | ​ | ​ | 15,276,116 | ​
Equity Valuations: Stock option grant date fair values are calculated based on the binomial/lattice method option pricing model as of date of grant. Adjustments have been made using stock option fair values as of each measurement date using the stock price as of the measurement date and updated assumptions (i.e., term, volatility, dividend yield, risk free rates) as of the measurement date. Restricted share unit grant date fair values are calculated using the stock price as of date of grant. Adjustments have been made using the stock price as of year-end and as of each date of vest. |  |  |  |
Company Selected Measure Name | Global Revenue |  |  |  |
Named Executive Officers, Footnote | (1) The dollar amounts reported are the amounts of total compensation reported for our Chief Executive Officer, John V. Oyler, in the Summary Compensation Table for fiscal years 2024, 2023, 2022, 2021 and 2020. John V. Oyler served as Chief Executive Officer for each of the years presented. (3) For 2024, reflects compensation information for our named executive officers, other than our Chief Executive Officer, as described in the Compensation Discussion and Analysis portion of this proxy statement. For 2023, reflects compensation information for Xiaobin Wu, Julia Wang, Lai Wang and Chan Lee. For 2022, reflects compensation information for Xiaobin Wu, Julia Wang, Lai Wang, and Jane Huang. For 2021, reflects compensation information for Xiaobin Wu, Lai Wang, Julia Wang, Jane Huang and Howard Liang. For 2020, reflects compensation information for Xiaobin Wu, Jane Huang and Howard Liang. |  |  |  |
Peer Group Issuers, Footnote | (4) Reflects cumulative total shareholder return of the Nasdaq Biotechnology Index, as of December 31, 2024, weighted according to the constituent companies’ market capitalization at the beginning of each period for which a return is indicated. The Nasdaq Biotechnology Index is the peer group used by the Company for purposes of Item 201(e) of Regulation S-K under the Exchange Act in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. |  |  |  |
PEO Total Compensation Amount | $ 20,836,439 | $ 18,925,730 | $ 18,047,667 | $ 16,748,546 | $ 14,409,330
PEO Actually Paid Compensation Amount | $ 14,972,388 | 11,431,433 | 11,216,389 | 22,876,853 | 40,749,054
Adjustment To PEO Compensation, Footnote | To calculate the amounts in the “Compensation Actually Paid to CEO” column in the table above, the following amounts were deducted from and added to (as applicable) our CEO’s “Total” compensation as reported in the Summary Compensation Table:
​ | ​ | ​ | 2024($) | ​ | ​ | 2023($) | ​ | ​ | 2022($) | ​ | ​ | 2021($) | ​ | ​ | 2020($) | ​
Summary Compensation Table Values | ​ | ​ | 20,836,439 | ​ | ​ | 18,925,730 | ​ | ​ | 18,047,667 | ​ | ​ | 16,748,546 | ​ | ​ | 14,409,330 | ​
Adjustments | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Deduction for grant date fair value amounts reported under “Share Awards” column in the Summary Compensation Table | ​ | ​ | (11,999,768) | ​ | ​ | (5,499,851) | ​ | ​ | (3,999,886) | ​ | ​ | (3,749,738) | ​ | ​ | — | ​
Deduction for grant date fair value amounts reported under “Option Awards” column in the Summary Compensation Table | ​ | ​ | (5,999,924) | ​ | ​ | (10,999,987) | ​ | ​ | (11,999,969) | ​ | ​ | (11,249,988) | ​ | ​ | (12,999,981) | ​
Year-over-Year change in the fair value of the Share Awards and Option Awards | ​ | ​ | 12,135,641 | ​ | ​ | 9,005,541 | ​ | ​ | 9,168,577 | ​ | ​ | 21,128,033 | ​ | ​ | 39,339,705 | ​
As of year-end for share awards granted during the year | ​ | ​ | 13,937,478 | ​ | ​ | 4,934,109 | ​ | ​ | 5,650,918 | ​ | ​ | 3,047,963 | ​ | ​ | — | ​
Year-over-year increase (decrease) of unvested share awards granted in prior years | ​ | ​ | (2,741,728) | ​ | ​ | (3,016,530) | ​ | ​ | (5,169,361) | ​ | ​ | (6,167,656) | ​ | ​ | (437,376) | ​
Increase (decrease) from prior fiscal year-end for share awards that vested during the year | ​ | ​ | 2,571,754 | ​ | ​ | 1,757,090 | ​ | ​ | 2,790,149 | ​ | ​ | 8,513,109 | ​ | ​ | 4,262,798 | ​
Decrease in fair value of share awards forfeited during the year | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​
As of year-end for option awards granted during the year | ​ | ​ | 7,170,732 | ​ | ​ | 8,881,173 | ​ | ​ | 19,018,564 | ​ | ​ | 8,085,256 | ​ | ​ | 21,214,314 | ​
Year-over-year increase (decrease) of unvested option awards granted in prior years | ​ | ​ | (9,374,770) | ​ | ​ | (15,862,437) | ​ | ​ | (22,568,170) | ​ | ​ | (22,321,474) | ​ | ​ | (18,976,117) | ​
Increase (decrease) from prior fiscal year-end for option awards that vested during the year | ​ | ​ | 572,175 | ​ | ​ | 12,312,136 | ​ | ​ | 9,446,478 | ​ | ​ | 29,970,835 | ​ | ​ | 33,276,085 | ​
Decrease in fair value of option awards forfeited during the year | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​
“Compensation Actually Paid” as defined by SEC rules | ​ | ​ | 14,972,388 | ​ | ​ | 11,431,433 | ​ | ​ | 11,216,389 | ​ | ​ | 22,876,853 | ​ | ​ | 40,749,054 | ​
Non-PEO NEO Average Total Compensation Amount | $ 7,938,281 | 7,108,129 | 6,355,270 | 5,143,513 | 5,178,425
Non-PEO NEO Average Compensation Actually Paid Amount | $ 6,673,955 | 6,652,989 | 3,367,166 | 5,761,306 | 15,276,116
Adjustment to Non-PEO NEO Compensation Footnote | To calculate the amounts in the “Average Compensation Actually Paid to Non-CEO NEOs” column in the table above, the following amounts were deducted from and added to (as applicable) the average of the “Total” compensation of our non-CEO named executive officers for each applicable year as reported in the Summary Compensation Table:
​ | ​ | ​ | 2024($) | ​ | ​ | 2023($) | ​ | ​ | 2022($) | ​ | ​ | 2021($) | ​ | ​ | 2020($) | ​
Average Summary Compensation Table Values | ​ | ​ | 7,938,281 | ​ | ​ | 7,108,129 | ​ | ​ | 6,355,270 | ​ | ​ | 5,143,513 | ​ | ​ | 5,178,425 | ​
Adjustments | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Deduction for average grant date fair value of amounts reported to Non-CEO NEOs under “Share Awards” column in the Summary Compensation Table | ​ | ​ | (3,879,868) | ​ | ​ | (1,961,799) | ​ | ​ | (1,530,694) | ​ | ​ | (1,301,952) | ​ | ​ | (1,066,581) | ​
Deduction for average grant date fair value of amounts reported to Non-CEO NEOs under “Option Awards” column in the Summary Compensation Table | ​ | ​ | (1,939,970) | ​ | ​ | (3,923,789) | ​ | ​ | (3,878,829) | ​ | ​ | (2,962,605) | ​ | ​ | (3,199,969) | ​
Year-over-Year change in the average fair value of the Share Awards and Option Awards | ​ | ​ | 4,555,512 | ​ | ​ | 5,430,448 | ​ | ​ | 2,421,419 | ​ | ​ | 4,882,350 | ​ | ​ | 14,364,241 | ​
As of year-end for share awards granted during the year | ​ | ​ | 3,631,546 | ​ | ​ | 1,759,998 | ​ | ​ | 2,027,077 | ​ | ​ | 773,830 | ​ | ​ | 1,579,969 | ​
Year-over-year increase (decrease) of unvested share awards granted in prior years | ​ | ​ | (629,516) | ​ | ​ | (1,396,018) | ​ | ​ | (3,171,371) | ​ | ​ | (1,711,290) | ​ | ​ | 1,084,830 | ​
Increase (decrease) from prior fiscal year-end for share awards that vested during the year | ​ | ​ | 1,219,522 | ​ | ​ | 2,656,725 | ​ | ​ | 1,518,326 | ​ | ​ | 3,166,184 | ​ | ​ | 1,653,429 | ​
Decrease in fair value of share awards forfeited during the year | ​ | ​ | (1,039,985) | ​ | ​ | — | ​ | ​ | (307,302) | ​ | ​ | (369,601) | ​ | ​ | — | ​
As of year-end for option awards granted during the year | ​ | ​ | 1,849,707 | ​ | ​ | 3,167,990 | ​ | ​ | 5,943,252 | ​ | ​ | 2,052,737 | ​ | ​ | 5,221,946 | ​
Year-over-year increase (decrease) of unvested option awards granted in prior years | ​ | ​ | (2,366,351) | ​ | ​ | (3,948,214) | ​ | ​ | (4,561,808) | ​ | ​ | (4,842,349) | ​ | ​ | (2,274,007) | ​
Increase (decrease) from prior fiscal year-end for option awards that vested during the year | ​ | ​ | 2,551,974 | ​ | ​ | 3,189,968 | ​ | ​ | 1,981,811 | ​ | ​ | 7,018,416 | ​ | ​ | 7,098,075 | ​
Decrease in fair value of option awards forfeited during the year | ​ | ​ | (661,385) | ​ | ​ | — | ​ | ​ | (1,008,565) | ​ | ​ | (1,205,576) | ​ | ​ | — | ​
Average “Compensation Actually Paid” as defined by SEC rules | ​ | ​ | 6,673,955 | ​ | ​ | 6,652,989 | ​ | ​ | 3,367,166 | ​ | ​ | 5,761,306 | ​ | ​ | 15,276,116 | ​
Equity Valuation Assumption Difference, Footnote | Equity Valuations: Stock option grant date fair values are calculated based on the binomial/lattice method option pricing model as of date of grant. Adjustments have been made using stock option fair values as of each measurement date using the stock price as of the measurement date and updated assumptions (i.e., term, volatility, dividend yield, risk free rates) as of the measurement date. Restricted share unit grant date fair values are calculated using the stock price as of date of grant. Adjustments have been made using the stock price as of year-end and as of each date of vest. |  |  |  |
Compensation Actually Paid vs. Total Shareholder Return |  |  |  |  |
Compensation Actually Paid vs. Net Income |  |  |  |  |
Compensation Actually Paid vs. Company Selected Measure |  |  |  |  |
Total Shareholder Return Vs Peer Group |  |  |  |  |
Tabular List, Table | Pay-Versus-Performance Alignment The following table identifies three of the financial performance measures used by our Compensation Committee to link the “compensation actually paid” ​(“CAP”) to our Chief Executive Officer and other named executive officers in 2024, calculated in accordance with SEC regulations, to company performance. The role of each of these performance measures on our named executive officers’ compensation is discussed in the Compensation Discussion and Analysis above.
​ | Financial Performance Measures | ​
​ | Global Revenue | ​ | ​ | ​ | Research & Innovation | ​ | ​ | ​ | Non-GAAP Operating Income (Loss) | ​
Total Shareholder Return Amount | $ 111 | 109 | 133 | 163 | 156
Peer Group Total Shareholder Return Amount | 118 | 119 | 114 | 126 | 126
Net Income (Loss) | $ (644,786,000) | $ (881,708,000) | $ (2,003,815,000) | $ (1,457,816,000) | $ (1,624,974,000)
Company Selected Measure Amount | 3,810,241,000 | 2,458,779,000 | 1,415,921,000 | 1,176,283,000 | 308,874,000
PEO Name | John V. Oyler |  |  |  |
Measure:: 1 |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Name | Global Revenue |  |  |  |
Non-GAAP Measure Description | (5) The Company has identified Global Revenue as the company-selected financial measure for the pay versus performance disclosure, as it represents the most important financial performance measure used to link “Compensation Actually Paid” to the executive officers in 2024 to the Company’s performance. |  |  |  |
Measure:: 2 |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Name | Research & Innovation |  |  |  |
Measure:: 3 |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Name | Non-GAAPOperating Income (Loss) |  |  |  |
PEO | Equity Awards Adjustments, Excluding Value Reported in Compensation Table |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | $ 12,135,641 | $ 9,005,541 | $ 9,168,577 | $ 21,128,033 | $ 39,339,705
PEO | Equity Share Awards Value In Summary Compensation Table (Grant Date Value) |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | (11,999,768) | (5,499,851) | (3,999,886) | (3,749,738) |
PEO | Equity Optiion Awards Value In Summary Compensation Table (Grant Date Value) |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | (5,999,924) | (10,999,987) | (11,999,969) | (11,249,988) | (12,999,981)
PEO | Year-end Fair Value Of Share Awards Granted In The Current Fiscal Year [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 13,937,478 | 4,934,109 | 5,650,918 | 3,047,963 |
PEO | Change In Fair Value Of Outstanding And Unvested Share Awards Granted In Prior Fiscal Years [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | (2,741,728) | (3,016,530) | (5,169,361) | (6,167,656) | (437,376)
PEO | Change In Fair Value As Of Vesting Date Of Prior Year Share Awards Vested During Current Year [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 2,571,754 | 1,757,090 | 2,790,149 | 8,513,109 | 4,262,798
PEO | Decrease In Fair Value Of Share Awards Forfeited During Current Year [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount |  |  |  |  |
PEO | Year-end Fair Value Of Option Awards Granted In The Current Fiscal Year [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 7,170,732 | 8,881,173 | 19,018,564 | 8,085,256 | 21,214,314
PEO | Change In Fair Value Of Outstanding And Unvested Option Awards Granted In Prior Fiscal Years [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | (9,374,770) | (15,862,437) | (22,568,170) | (22,321,474) | (18,976,117)
PEO | Change In Fair Value As Of Vesting Date Of Prior Year Option Awards Vested During Current Year [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 572,175 | 12,312,136 | 9,446,478 | 29,970,835 | 33,276,085
PEO | Decrease In Fair Value Of Option Awards Forfeited During Current Year [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount |  |  |  |  |
Non-PEO NEO | Equity Awards Adjustments, Excluding Value Reported in Compensation Table |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 4,555,512 | 5,430,448 | 2,421,419 | 4,882,350 | 14,364,241
Non-PEO NEO | Equity Share Awards Value In Summary Compensation Table (Grant Date Value) |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | (3,879,868) | (1,961,799) | (1,530,694) | (1,301,952) | (1,066,581)
Non-PEO NEO | Equity Optiion Awards Value In Summary Compensation Table (Grant Date Value) |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | (1,939,970) | (3,923,789) | (3,878,829) | (2,962,605) | (3,199,969)
Non-PEO NEO | Year-end Fair Value Of Share Awards Granted In The Current Fiscal Year [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 3,631,546 | 1,759,998 | 2,027,077 | 773,830 | 1,579,969
Non-PEO NEO | Change In Fair Value Of Outstanding And Unvested Share Awards Granted In Prior Fiscal Years [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | (629,516) | (1,396,018) | (3,171,371) | (1,711,290) | 1,084,830
Non-PEO NEO | Change In Fair Value As Of Vesting Date Of Prior Year Share Awards Vested During Current Year [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 1,219,522 | 2,656,725 | 1,518,326 | 3,166,184 | 1,653,429
Non-PEO NEO | Decrease In Fair Value Of Share Awards Forfeited During Current Year [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | (1,039,985) |  | (307,302) | (369,601) |
Non-PEO NEO | Year-end Fair Value Of Option Awards Granted In The Current Fiscal Year [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 1,849,707 | 3,167,990 | 5,943,252 | 2,052,737 | 5,221,946
Non-PEO NEO | Change In Fair Value Of Outstanding And Unvested Option Awards Granted In Prior Fiscal Years [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | (2,366,351) | (3,948,214) | (4,561,808) | (4,842,349) | (2,274,007)
Non-PEO NEO | Change In Fair Value As Of Vesting Date Of Prior Year Option Awards Vested During Current Year [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 2,551,974 | 3,189,968 | 1,981,811 | 7,018,416 | 7,098,075
Non-PEO NEO | Decrease In Fair Value Of Option Awards Forfeited During Current Year [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | $ (661,385) |  | $ (1,008,565) | $ (1,205,576) |

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToNonPeoNeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToPeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph iii + Details
Name: | ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph ii + Details
Name: | ecd_CompActuallyPaidVsNetIncomeTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph i + Details
Name: | ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 4 + Details
Name: | ecd_EquityValuationAssumptionDifferenceFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_MeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_NamedExecutiveOfficersFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_NonGaapMeasureDescriptionTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_NonPeoNeoAvgCompActuallyPaidAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_NonPeoNeoAvgTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_PeerGroupIssuersFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_PeerGroupTotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_PeoActuallyPaidCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_PeoName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_PeoTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTable
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 6 + Details
Name: | ecd_TabularListTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnVsPeerGroupTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 60 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 323 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4 Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(1)(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 32: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7 Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28 Reference 35: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1 + Details
Name: | us-gaap_NetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ecd_MeasureAxis=1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=3
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_PeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=bgne_EquityShareAwardsValueInCompensationTableForTheApplicableYearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=bgne_EquityOptionAwardsValueInCompensationTableForTheApplicableYearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=bgne_EquityAwardsAdjustmentsYearEndFairValueOfShareAwardsGrantedInCurrentYearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=bgne_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedShareAwardsGrantedInPriorYearsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=bgne_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearShareAwardsVestedDuringCurrentYearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=bgne_EquityAdjustmentsAwardsIncreaseDecreaseInFairValueOfShareAwardsForfeitedDuringCurrentYearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=bgne_EquityAwardsAdjustmentsYearEndFairValueOfOptionAwardsGrantedInCurrentYearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=bgne_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedOptionAwardsGrantedInPriorYearsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=bgne_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearOptionAwardsVestedDuringCurrentYearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=bgne_EquityAdjustmentsAwardsIncreaseDecreaseInFairValueOfOptionAwardsForfeitedDuringCurrentYearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |